Copyright Reports & Markets. All rights reserved.

Global Immune Repertoire Sequencing Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Immune Repertoire Sequencing Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Immune Repertoire Sequencing Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Pyro-Sequencing
    • 1.4.3 Dye-Terminating Sequencing
    • 1.4.4 Semiconductor Sequencing
    • 1.4.5 Others
  • 1.5 Market by Application
    • 1.5.1 Global Immune Repertoire Sequencing Market Share by Application: 2020 VS 2026
    • 1.5.2 Biomarker Discovery
    • 1.5.3 Infectious Diseases
    • 1.5.4 Vaccine Development and Efficacy
    • 1.5.5 Cancer Immunotherapy
    • 1.5.6 Autoimmune Disease
    • 1.5.7 Transplant Rejection and Tolerance
    • 1.5.8 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Immune Repertoire Sequencing Market Perspective (2015-2026)
  • 2.2 Global Immune Repertoire Sequencing Growth Trends by Regions
    • 2.2.1 Immune Repertoire Sequencing Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Immune Repertoire Sequencing Historic Market Share by Regions (2015-2020)
    • 2.2.3 Immune Repertoire Sequencing Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Immune Repertoire Sequencing Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Immune Repertoire Sequencing Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Immune Repertoire Sequencing Players by Market Size
    • 3.1.1 Global Top Immune Repertoire Sequencing Players by Revenue (2015-2020)
    • 3.1.2 Global Immune Repertoire Sequencing Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Immune Repertoire Sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Immune Repertoire Sequencing Market Concentration Ratio
    • 3.2.1 Global Immune Repertoire Sequencing Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Immune Repertoire Sequencing Revenue in 2019
  • 3.3 Immune Repertoire Sequencing Key Players Head office and Area Served
  • 3.4 Key Players Immune Repertoire Sequencing Product Solution and Service
  • 3.5 Date of Enter into Immune Repertoire Sequencing Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Immune Repertoire Sequencing Historic Market Size by Type (2015-2020)
  • 4.2 Global Immune Repertoire Sequencing Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Immune Repertoire Sequencing Market Size by Application (2015-2020)
  • 5.2 Global Immune Repertoire Sequencing Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Immune Repertoire Sequencing Market Size (2015-2020)
  • 6.2 Immune Repertoire Sequencing Key Players in North America (2019-2020)
  • 6.3 North America Immune Repertoire Sequencing Market Size by Type (2015-2020)
  • 6.4 North America Immune Repertoire Sequencing Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Immune Repertoire Sequencing Market Size (2015-2020)
  • 7.2 Immune Repertoire Sequencing Key Players in Europe (2019-2020)
  • 7.3 Europe Immune Repertoire Sequencing Market Size by Type (2015-2020)
  • 7.4 Europe Immune Repertoire Sequencing Market Size by Application (2015-2020)

8 China

  • 8.1 China Immune Repertoire Sequencing Market Size (2015-2020)
  • 8.2 Immune Repertoire Sequencing Key Players in China (2019-2020)
  • 8.3 China Immune Repertoire Sequencing Market Size by Type (2015-2020)
  • 8.4 China Immune Repertoire Sequencing Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Immune Repertoire Sequencing Market Size (2015-2020)
  • 9.2 Immune Repertoire Sequencing Key Players in Japan (2019-2020)
  • 9.3 Japan Immune Repertoire Sequencing Market Size by Type (2015-2020)
  • 9.4 Japan Immune Repertoire Sequencing Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Immune Repertoire Sequencing Market Size (2015-2020)
  • 10.2 Immune Repertoire Sequencing Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Immune Repertoire Sequencing Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Immune Repertoire Sequencing Market Size by Application (2015-2020)

11 India

  • 11.1 India Immune Repertoire Sequencing Market Size (2015-2020)
  • 11.2 Immune Repertoire Sequencing Key Players in India (2019-2020)
  • 11.3 India Immune Repertoire Sequencing Market Size by Type (2015-2020)
  • 11.4 India Immune Repertoire Sequencing Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Immune Repertoire Sequencing Market Size (2015-2020)
  • 12.2 Immune Repertoire Sequencing Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Immune Repertoire Sequencing Market Size by Type (2015-2020)
  • 12.4 Central & South America Immune Repertoire Sequencing Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 ArcherDX
    • 13.1.1 ArcherDX Company Details
    • 13.1.2 ArcherDX Business Overview
    • 13.1.3 ArcherDX Immune Repertoire Sequencing Introduction
    • 13.1.4 ArcherDX Revenue in Immune Repertoire Sequencing Business (2015-2020))
    • 13.1.5 ArcherDX Recent Development
  • 13.2 Junom Therapeutics
    • 13.2.1 Junom Therapeutics Company Details
    • 13.2.2 Junom Therapeutics Business Overview
    • 13.2.3 Junom Therapeutics Immune Repertoire Sequencing Introduction
    • 13.2.4 Junom Therapeutics Revenue in Immune Repertoire Sequencing Business (2015-2020)
    • 13.2.5 Junom Therapeutics Recent Development
  • 13.3 Roche Holding
    • 13.3.1 Roche Holding Company Details
    • 13.3.2 Roche Holding Business Overview
    • 13.3.3 Roche Holding Immune Repertoire Sequencing Introduction
    • 13.3.4 Roche Holding Revenue in Immune Repertoire Sequencing Business (2015-2020)
    • 13.3.5 Roche Holding Recent Development
  • 13.4 Illumina
    • 13.4.1 Illumina Company Details
    • 13.4.2 Illumina Business Overview
    • 13.4.3 Illumina Immune Repertoire Sequencing Introduction
    • 13.4.4 Illumina Revenue in Immune Repertoire Sequencing Business (2015-2020)
    • 13.4.5 Illumina Recent Development
  • 13.5 ThermoFisher Scietific
    • 13.5.1 ThermoFisher Scietific Company Details
    • 13.5.2 ThermoFisher Scietific Business Overview
    • 13.5.3 ThermoFisher Scietific Immune Repertoire Sequencing Introduction
    • 13.5.4 ThermoFisher Scietific Revenue in Immune Repertoire Sequencing Business (2015-2020)
    • 13.5.5 ThermoFisher Scietific Recent Development
  • 13.6 Pacific Biosciences
    • 13.6.1 Pacific Biosciences Company Details
    • 13.6.2 Pacific Biosciences Business Overview
    • 13.6.3 Pacific Biosciences Immune Repertoire Sequencing Introduction
    • 13.6.4 Pacific Biosciences Revenue in Immune Repertoire Sequencing Business (2015-2020)
    • 13.6.5 Pacific Biosciences Recent Development
  • 13.7 CD Genomics
    • 13.7.1 CD Genomics Company Details
    • 13.7.2 CD Genomics Business Overview
    • 13.7.3 CD Genomics Immune Repertoire Sequencing Introduction
    • 13.7.4 CD Genomics Revenue in Immune Repertoire Sequencing Business (2015-2020)
    • 13.7.5 CD Genomics Recent Development
  • 13.8 Atreca
    • 13.8.1 Atreca Company Details
    • 13.8.2 Atreca Business Overview
    • 13.8.3 Atreca Immune Repertoire Sequencing Introduction
    • 13.8.4 Atreca Revenue in Immune Repertoire Sequencing Business (2015-2020)
    • 13.8.5 Atreca Recent Development
  • 13.9 Adaptive Biotechnologies
    • 13.9.1 Adaptive Biotechnologies Company Details
    • 13.9.2 Adaptive Biotechnologies Business Overview
    • 13.9.3 Adaptive Biotechnologies Immune Repertoire Sequencing Introduction
    • 13.9.4 Adaptive Biotechnologies Revenue in Immune Repertoire Sequencing Business (2015-2020)
    • 13.9.5 Adaptive Biotechnologies Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Immune Repertoire Sequencing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Immune Repertoire Sequencing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    ArcherDX
    Junom Therapeutics
    Roche Holding
    Illumina
    ThermoFisher Scietific
    Pacific Biosciences
    CD Genomics
    Atreca
    Adaptive Biotechnologies

    Market segment by Type, the product can be split into
    Pyro-Sequencing
    Dye-Terminating Sequencing
    Semiconductor Sequencing
    Others
    Market segment by Application, split into
    Biomarker Discovery
    Infectious Diseases
    Vaccine Development and Efficacy
    Cancer Immunotherapy
    Autoimmune Disease
    Transplant Rejection and Tolerance
    Others

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now